INTECH Investment Management’s Beam Therapeutics BEAM Stock Holding History

INTECH Investment Management’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$778K	Sell	22,673 -9,447	-29%	-$285K	0.01%	1149
2026 Q1	$765K	Sell	32,120 -5,933	-16%	-$165K	0.01%	1129
2025 Q4	$1.05M	Buy	38,053 +10,228	+37%	+$261K	0.01%	1106
2025 Q3	$675K	Sell	27,825 -18,380	-40%	-$366K	0.01%	1406
2025 Q2	$786K	Buy	46,205 +1,530	+3%	+$26.6K	0.01%	1350
2025 Q1	$873K	Buy	44,675 +15,274	+52%	+$400K	0.01%	1284
2024 Q4	$729K	Buy	29,401 +8,509	+41%	+$217K	0.01%	1339
2024 Q3	$512K	Buy	+20,892	New	+$540K	0.01%	1219

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

INTECH Investment Management's BEAM Position: Q2 2026 in Review

INTECH Investment Management reduced its Beam Therapeutics (BEAM) stake by 29% in Q2 2026, selling an estimated $285K and leaving 22,673 shares worth $778K. The position accounts for 0.01% of the portfolio, ranked #1149.

INTECH Investment Management first reported a position in BEAM in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.05M in Q4 2025. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

INTECH Investment Management held 22,673 shares of Beam Therapeutics worth $778K as of Q2 2026.
INTECH Investment Management sold 9,447 Beam Therapeutics shares in Q2 2026, an estimated $285K.
Beam Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1149 holding.
INTECH Investment Management first reported a position in Beam Therapeutics in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Beam Therapeutics position peaked at $1.05M in Q4 2025.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.